WuXi NextCODE to Offer The New Pan-Cancer TSO 500 Biomarker Assay from Illumina
WuXi NextCODE offers access to Illumina's TruSightTM Oncology 500 (TSO 500).
At the annual American College of Medical Genetics (ACMG) meeting, Yi Huang, PhD, senior scientist and team leader for clinical analysis for medical/whole exome sequencing, presented on her lab’s experience with over 10,000 cases carried out from 2016-2017. Their results are one more sign that genomics in China is keeping up with the best facilities in the world.
In an industry first, a hand-held device sequences the entire human genome with 99.96% accuracy.
CEO Hannes Smarason's highlights from the JP Morgan Healthcare Conference